+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report by Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), Disease Indication (Chemotherapy, Diabetes, Gastroenterology), and Region with Growth Forecasts, 2025-2030- Product Image
Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report by Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), Disease Indication (Chemotherapy, Diabetes, Gastroenterology), and Region with Growth Forecasts, 2025-2030- Product Image
New

Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report by Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), Disease Indication (Chemotherapy, Diabetes, Gastroenterology), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5415482
Description Jump to:
The Intravenous Infusion Pumps Market was valued at USD 6.15 billion in 2024, and is projected to reach USD 9.98 billion by 2030, rising at a CAGR of 8.50%. The increasing prevalence of chronic conditions, including cancer, diabetes, cardiovascular, and respiratory diseases, necessitates precise medication and therapy administration, thereby driving the demand for infusion pumps.

The global aging population further amplifies the adoption of infusion pumps, particularly in outpatient and home care settings, where they facilitate safe and accurate drug delivery for elderly patients managing complex medication regimens. The World Health Organization reported that life expectancy at birth increased to 73.3 years in 2024, a rise of 8.4 years since 1995. Moreover, the global population aged 60 and older is projected to reach 1.4 billion by 2030, up from 1.1 billion in 2023, highlighting the growing need for such technologies.

Technological advancements in infusion pump capabilities significantly bolster market demand. Smart infusion pumps, featuring wireless connectivity, EHR integration, and automated programming, enhance patient safety and operational efficiency by minimizing medication errors and streamlining workflows

Intravenous Infusion Pumps Report Highlights

  • Volumetric infusion pumps held the largest market share in the product segment in 2024. Their efficacy in delivering large volumes precisely is vital in managing chronic diseases such as cancer and diabetes and in surgical procedures.
  • Insulin infusion pumps are projected to grow at the fastest CAGR of over 9.0% over the forecast period. The global rise in diabetes prevalence, primarily due to aging populations, unhealthy lifestyles, and increasing obesity rates, has driven insulin pump demand.
  • Pediatrics/neonatology dominated the disease indication segment with over 25.0% of the total revenue share in 2024.
  • The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period, driven by the rising number of cancer cases and rapid development in oncological drugs.
  • North America dominated the intravenous infusion pumps market due to its advanced medical infrastructure, increasing chronic disease prevalence, and technological advancements.
  • In May 2024, Moog Inc. received FDA 510(k) clearance for its CURLIN 8000 Ambulatory Infusion System. This new multi-therapy platform was designed for enhanced usability and safety in home infusion settings.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Disease Indication
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Disease indication outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Intravenous Infusion Pumps Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Intravenous Infusion Pumps Market: Pipeline Analysis
Chapter 4. Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis
4.1. Product Segment Dashboard
4.2. Intravenous Infusion Pumps Market: Product Movement Analysis
4.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Volumetric Infusion Pumps
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Syringe Infusion Pumps
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Insulin Infusion Pumps
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Enteral Infusion Pumps
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Ambulatory Infusion Pumps
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Patient-Controlled Analgesia Infusion Pumps
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Implantable Infusion Pumps
4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Others
4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis
5.1. Disease Indication Segment Dashboard
5.2. Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
5.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
5.4. Chemotherapy
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Diabetes
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Gastroenterology
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Analgesia/Pain Management
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Pediatrics/Neonatology
5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Hematology
5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Others
5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Intravenous infusion pumps market by Region: Key Takeaways
6.4. North America
6.4.1. U.S.
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Europe
6.5.1. UK
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. France
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Denmark
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.5.7. Sweden
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.5.8. Norway
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Asia Pacific
6.6.1. China
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. India
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Australia
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Argentina
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework/ reimbursement structure
6.8.4.3. Competitive scenario
6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. Baxter
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. B. Braun Medical Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Medtronic
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Micrel Medical Devices SA
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Boston Scientific Corporation
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Cardinal Health
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Fresenius Kabi AG
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. ICU Medical, Inc.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. F. Hoffmann-La Roche Ltd
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Tandem Diabetes Care, Inc.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Terumo Corporation
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. Moog Inc.
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. IRadimed Corporation
7.4.14.1. Company overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global intravenous infusion pumps market, by region, 2018-2030 (USD Million)
Table 3 Global intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 4 Global intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 5 North America intravenous infusion pumps market, by country, 2018-2030 (USD Million)
Table 6 North America intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 7 North America intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 8 U.S. intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 9 U.S. intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 10 Canada intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 11 Canada intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 12 Mexico intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 13 Mexico surgical ablation market, by disease indication, 2018-2030 (USD Million)
Table 14 Europe intravenous infusion pumps market, by country, 2018-2030 (USD Million)
Table 15 Europe intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 16 Europe intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 17 UK intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 18 UK intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 19 Germany intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 20 Germany intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 21 France intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 22 France intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 23 Italy intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 24 Italy intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 25 Spain intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 26 Spain intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 27 Denmark intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 28 Denmark intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 29 Sweden intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 30 Sweden intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 31 Norway intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 32 Norway intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 33 Asia Pacific intravenous infusion pumps market, by country, 2018-2030 (USD Million)
Table 34 Asia Pacific intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 35 Asia Pacific intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 36 China intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 37 China intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 38 Japan intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 39 Japan intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 40 India intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 41 India intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 42 Australia intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 43 Australia intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 44 South Korea intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 45 South Korea intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 46 Thailand intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 47 Thailand intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 48 Latin America intravenous infusion pumps market, by country, 2018-2030 (USD Million)
Table 49 Latin America intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 50 Latin America laparoscopic ablation market, by disease indication, 2018-2030 (USD Million)
Table 51 Latin America percutaneous ablation market, by disease indication, 2018-2030 (USD Million)
Table 52 Latin America intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 53 Brazil intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 54 Brazil surgical ablation market, by disease indication, 2018-2030 (USD Million)
Table 55 Argentina intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 56 Argentina surgical ablation market, by disease indication, 2018-2030 (USD Million)
Table 57 MEA intravenous infusion pumps market, by region, 2018-2030 (USD Million)
Table 58 MEA intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 59 MEA intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 60 South Africa intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 61 South Africa intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 62 Saudi Arabia intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 63 Saudi Arabia intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 64 UAE intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 65 UAE intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
Table 66 Kuwait intravenous infusion pumps market, by product, 2018-2030 (USD Million)
Table 67 Kuwait intravenous infusion pumps market, by disease indication, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Intravenous infusion pumps market: market outlook
Figure 10 Intravenous infusion pumps competitive insights
Figure 11 Parent market outlook
Figure 12 Related/ancillary market outlook
Figure 13 Penetration and growth prospect mapping
Figure 14 Industry value chain analysis
Figure 15 Intravenous infusion pumps market driver impact
Figure 16 Intravenous infusion pumps market restraint impact
Figure 17 Intravenous infusion pumps market strategic initiatives analysis
Figure 18 Intravenous infusion pumps market: Product movement analysis
Figure 19 Intravenous infusion pumps market: Product outlook and key takeaways
Figure 20 Volumetric infusion pumps estimates and forecast, 2018-2030
Figure 21 Syringe infusion pumps estimates and forecast, 2018-2030
Figure 22 Insulin infusion pumps estimates and forecast, 2018-2030
Figure 23 Enteral infusion pumps estimates and forecast, 2018-2030
Figure 24 Ambulatory infusion pumps estimates and forecast, 2018-2030
Figure 25 Patient-controlled analgesia infusion pumps estimates and forecast, 2018-2030
Figure 26 Implantable infusion pumps estimates and forecast, 2018-2030
Figure 27 Others estimates and forecast, 2018-2030
Figure 28 Intravenous infusion pumps market: Disease indication movement analysis
Figure 29 Intravenous infusion pumps market: Disease indication outlook and key takeaways
Figure 30 Chemotherapy estimates and forecast, 2018-2030
Figure 31 Diabetes estimates and forecast, 2018-2030
Figure 32 Gastroenterology estimates and forecast, 2018-2030
Figure 33 Analgesia/pain management estimates and forecast, 2018-2030
Figure 34 Pediatrics/neonatology estimates and forecast, 2018-2030
Figure 35 Hematology estimates and forecast, 2018-2030
Figure 36 Others estimates and forecast, 2018-2030
Figure 37 Global intravenous infusion pumps market: Regional movement analysis
Figure 38 Global intravenous infusion pumps market: Regional outlook and key takeaways
Figure 39 North America market estimates and forecasts, 2018-2030
Figure 40 U.S. market estimates and forecasts, 2018-2030
Figure 41 Canada market estimates and forecasts, 2018-2030
Figure 42 Mexico market estimates and forecasts, 2018-2030
Figure 43 Europe market estimates and forecasts, 2018-2030
Figure 44 UK market estimates and forecasts, 2018-2030
Figure 45 Germany market estimates and forecasts, 2018-2030
Figure 46 France market estimates and forecasts, 2018-2030
Figure 47 Italy market estimates and forecasts, 2018-2030
Figure 48 Spain market estimates and forecasts, 2018-2030
Figure 49 Denmark market estimates and forecasts, 2018-2030
Figure 50 Sweden market estimates and forecasts, 2018-2030
Figure 51 Norway market estimates and forecasts, 2018-2030
Figure 52 Asia Pacific market estimates and forecasts, 2018-2030
Figure 53 China market estimates and forecasts, 2018-2030
Figure 54 Japan market estimates and forecasts, 2018-2030
Figure 55 India market estimates and forecasts, 2018-2030
Figure 56 Australia market estimates and forecasts, 2018-2030
Figure 57 South Korea market estimates and forecasts, 2018-2030
Figure 58 Thailand market estimates and forecasts, 2018-2030
Figure 59 Latin America market estimates and forecasts, 2018-2030
Figure 60 Brazil market estimates and forecasts, 2018-2030
Figure 61 Argentina market estimates and forecasts, 2018-2030
Figure 62 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 63 South Africa market estimates and forecasts, 2018-2030
Figure 64 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 65 UAE market estimates and forecasts, 2018-2030
Figure 66 Kuwait market estimates and forecasts, 2018-2030

Companies Mentioned

The major companies featured in this Intravenous Infusion Pumps market report include:
  • Baxter
  • B. Braun Medical Inc.
  • Medtronic
  • Micrel Medical Devices SA
  • Boston Scientific Corporation
  • Cardinal Health
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • F. Hoffmann-La Roche Ltd
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Moog Inc.
  • IRadimed Corporation

Table Information

Report AttributeDetails
No. of Pages100
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 6.15 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.98 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Intravenous Infusion Pump Market by End Use, Product Type, Technology, Application, Portability - Global Forecast to 2030 - Product Image

Intravenous Infusion Pump Market by End Use, Product Type, Technology, Application, Portability - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Intravenous Infusion Pumps - Global Strategic Business Report - Product Image

Intravenous Infusion Pumps - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Home Infusion Therapy Market by Product Type, Application, Service Model - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Home Infusion Therapy Market by Product Type, Application, Service Model - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 220 Pages
  • Global
From
Intravenous Infusion Pumps Market Report 2025 - Product Image

Intravenous Infusion Pumps Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.